Neuphoria Therapeutics Statistics
Total Valuation
NEUP has a market cap or net worth of $12.26 million. The enterprise value is -$4.61 million.
Important Dates
The last earnings date was Tuesday, May 20, 2025, after market close.
Earnings Date | May 20, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NEUP has 1.88 million shares outstanding. The number of shares has increased by 106.92% in one year.
Current Share Class | 1.88M |
Shares Outstanding | 1.88M |
Shares Change (YoY) | +106.92% |
Shares Change (QoQ) | +9.13% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 12.54% |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 2.10.
PE Ratio | 2.10 |
Forward PE | n/a |
PS Ratio | 0.78 |
Forward PS | n/a |
PB Ratio | 0.46 |
P/TBV Ratio | 0.97 |
P/FCF Ratio | 18.81 |
P/OCF Ratio | 18.81 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.01, with a Debt / Equity ratio of 0.01.
Current Ratio | 11.01 |
Quick Ratio | 11.00 |
Debt / Equity | 0.01 |
Debt / EBITDA | 1.63 |
Debt / FCF | 0.26 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.45% and return on invested capital (ROIC) is -1.25%.
Return on Equity (ROE) | 25.45% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | -1.25% |
Return on Capital Employed (ROCE) | -1.61% |
Revenue Per Employee | $652,613 |
Profits Per Employee | $242,792 |
Employee Count | 24 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -235,880 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 5.28 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 69.16 |
Average Volume (20 Days) | 25,119 |
Short Selling Information
The latest short interest is 20,311, so 1.08% of the outstanding shares have been sold short.
Short Interest | 20,311 |
Short Previous Month | 21,812 |
Short % of Shares Out | 1.08% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, NEUP had revenue of $15.66 million and earned $5.83 million in profits. Earnings per share was $0.00.
Revenue | 15.66M |
Gross Profit | 16.73M |
Operating Income | -470,681 |
Pretax Income | n/a |
Net Income | 5.83M |
EBITDA | -24,706 |
EBIT | -470,681 |
Earnings Per Share (EPS) | $0.00 |
Full Income Statement Balance Sheet
The company has $17.04 million in cash and $172,460 in debt, giving a net cash position of $16.87 million or $8.97 per share.
Cash & Cash Equivalents | 17.04M |
Total Debt | 172,460 |
Net Cash | 16.87M |
Net Cash Per Share | $8.97 |
Equity (Book Value) | 26.00M |
Book Value Per Share | 14.02 |
Working Capital | 15.54M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 651,512 |
Capital Expenditures | n/a |
Free Cash Flow | 651,512 |
FCF Per Share | $0.35 |
Full Cash Flow Statement Margins
Gross margin is 106.82%, with operating and profit margins of -3.01% and 37.20%.
Gross Margin | 106.82% |
Operating Margin | -3.01% |
Pretax Margin | 35.70% |
Profit Margin | 37.20% |
EBITDA Margin | -0.16% |
EBIT Margin | -3.01% |
FCF Margin | 4.16% |
Dividends & Yields
NEUP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -106.92% |
Shareholder Yield | -106.92% |
Earnings Yield | 47.54% |
FCF Yield | 5.32% |
Analyst Forecast
The average price target for NEUP is $21.00, which is 213.43% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.00 |
Price Target Difference | 213.43% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NEUP has an Altman Z-Score of -5.65 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.65 |
Piotroski F-Score | 4 |